The global market for postoperative pain is expected to be worth US$ 38.43 billion in 2023, rising to US$ 63.8 billion by 2033. The use of postoperative pain medications is expected to rise at a 5.2% CAGR during the forecast period.

From 2018 to 2022, the demand for postoperative pain medications increased at a CAGR of 4.7%. The market for postoperative pain was worth US$ 30.4 billion in 2018, and it is expected to exceed US$ 36.53 billion by 2022. The demand for postoperative pain treatment is expected to rise in the coming years as the number of traffic accidents, relative trauma injuries, and relative trauma injuries rises.

According to projections, the United States will control 87.9% of the postoperative pain market in North America by 2022. Adoption of opioid treatment is expected to reduce the rising prevalence of the opioid epidemic in North America, particularly in the United States. In 2018, for example, over 200 million opioid medications were prescribed and administered to patients in the United States.

Postoperative Pain Market: Segmentation

Valuable information covered in the FMI’s Postoperative Pain market report has been segregated into key segments and sub-segments.

By Drug Class:

  • Opioids
  • NSAIDs
  • Local Anesthetic
  • Acetaminophen

By Route of Administration:

  • Injectable
  • Oral
  • Topical
  • Transdermal
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Clinics
  • Others

Get More Insights@ https://www.futuremarketinsights.com/reports/postoperative-pain-market

Postoperative Pain Market: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Postoperative Pain market. Competitive information detailed in the Postoperative Pain market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Postoperative Pain market report.

Key players covered in the report include:

  • Novartis AG
  • Allergan plc
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Pfizer Inc.
  • Purdue Pharma L.P
  • Janssen Pharmaceuticals, Inc.
  • Endo International plc.
  • Pacira Pharmaceuticals Inc.
  • Egalet Corporation
  • GlaxoSmithKline Plc